MI
PROF

MMCAP International’s Profound Medical PROF Stock Holding History

MMCAP International’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.83M Buy
745,152
+213,790
+40% +$1.48M 0.42% 71
2025
Q4 		$4.18M Buy
531,362
+30,503
+6% +$196K 0.42% 59
2025
Q3 		$2.45M Buy
500,859
+10,000
+2% +$51K 0.28% 66
2025
Q2 		$2.9M Buy
490,859
+10,000
+2% +$52.9K 0.35% 49
2025
Q1 		$2.8M Sell
480,859
-9,141
-2% -$63.1K 0.48% 36
2024
Q4 		$3.68M Buy
+490,000
New +$3.76M 0.55% 35

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $183M AUM 38.9% 1-Year Est. Return

MMCAP International's PROF Position: Q1 2026 in Review

MMCAP International increased its Profound Medical (PROF) stake by 40% in Q1 2026, buying an estimated $1.48M and bringing the position to 745,152 shares worth $4.83M. The position accounts for 0.42% of the portfolio, ranked #71.

MMCAP International first reported a position in PROF in Q4 2024 and has held it in 6 quarters since. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • MMCAP International held 745,152 shares of Profound Medical worth $4.83M as of Q1 2026.
  • MMCAP International bought 213,790 Profound Medical shares in Q1 2026, an estimated $1.48M.
  • Profound Medical made up 0.42% of MMCAP International's portfolio in Q1 2026, its #71 holding.
  • MMCAP International first reported a position in Profound Medical in Q4 2024 and has held it in 6 quarters since.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on MMCAP International's 13F filing for Q1 2026, filed 15 May 2026.